Checklist for early recognition and treatment of acute illness and injury: An exploratory multicenter international quality-improvement study in the ICUs with variable resources by Vukoja, M, Dong, Y, Adhikari, NKJ, Schultz, MJ, Arabi, YM, Martin-Loeches, I, Hache, M, Gavrilovic, S, Kashyap, R, Gajic, O

A post hoc analysis of osmotherapy use in the erythropoietin in traumatic brain injury study-associations with acute kidney injury and mortality by Skrifvars, MB, Bailey, M, Moore, E, Mårtensson, J, French, C, Presneill, J, Nichol, A, Little, L, Duranteau, J, Huet, O, Haddad, S, Arabi, YM, McArthur, C, Cooper, DJ, Bendel, S, Bellomo, R

Management of adult sepsis in resource-limited settings: global expert consensus statements using a Delphi method by Thwaites, L, Nasa, P, Abbenbroek, B, Dat, VQ, Finfer, S, Kwizera, A, Ling, L, Lobo, SM, Sinto, R, Aditianingsih, D, Antonelli, M, Arabi, YM, Argent, A, Azevedo, L, Bennett, E, Chakrabarti, A, De Asis, K, De Waele, J, Divatia, JV, Estenssoro, E, Evans, L, Faiz, A, Hammond, NE, Hashmi, M

How the COVID-19 pandemic will change the future of critical care by Arabi, YM, Azoulay, E, Al-Dorzi, HM, Phua, J, Salluh, J, Binnie, A, Hodgson, C, Angus, DC, Cecconi, M, Du, B, Fowler, R, Gomersall, CD, Horby, P, Juffermans, NP, Kesecioglu, J, Kleinpell, RM, Machado, FR, Martin, GS, Meyfroidt, G, Rhodes, A, Rowan, K, Timsit, J-F, Vincent, J-L, Citerio, G

Effect of ribavirin and interferon on the outcome of critically ill patients with mers by Arabi, YM, Shalhoub, S, Omari, A, Mandourah, Y, Al-Hameed, F, Sindi, A, Alraddadi, B, Motairi, A, Khatib, K, Mommin, AA, Qushmaq, IA, Mady, A, Solaiman, O, Aithan, A, Balkhy, HH, Al-Raddadi, R, Rajab, A, Mekhlafi, GA, Harthy, A, Kharaba, A, Al-Jabbary, A, Pinto, R, Sadat, M, Mutairi, H, Qasim, E, Jose, J, Deeb, AM, Merson, L, Hayden, FG, Fowler, R, Aldawood, AS

Critically ill patients with the Middle East Respiratory Syndrome (MERS): a multicenter study by Arabi, YM, Al-Omari, A, Mandourah, Y, Al-Hameed, F, Sindi, A, Al-Raddadi, B, Shalhoub, S, Almotairi, A, Qushmaq, I, Alkhatib, K, Mady, A, Solaiman, O, Abdulmomen, A, Al-Aithan, A, Al-Ahmadi, M, Alradadi, R, Rajab, A, Almekhlafi, G, Alharthy, A, Alahmadi, M, Sadat, M, Almutairi, H, Abdukahil, S, Alqasim, E, Nasim, M, Toledo, A, Bafqeeh, F, Alshankeety, O, Anwar, A, Aldawood, A, Merson, L, Fowler, R, Hayden, F, Balkhy, H

Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial by Bradbury, CA, Lawler, PR, Stanworth, SJ, McVerry, BJ, McQuilten, Z, Higgins, AM, Mouncey, PR, Al-Beidh, F, Rowan, KM, Berry, LR, Lorenzi, E, Zarychanski, R, Arabi, YM, Annane, D, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bihari, S, Bonten, MJM, Brunkhorst, FM, Buzgau, A, Buxton, M, Carrier, M, Cheng, AC, Cove, M, Detry, MA, Estcourt, LJ, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Huang, DT, Horvat, CM, Hunt, BJ, Ichihara, N, Lamontagne, F, Leavis, HL, Linstrum, KM, Litton, E, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, Middeldorp, S, Montgomery, SK, Morpeth, SC, Murthy, S

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial by Arabi, YM, Gordon, AC, Derde, LPG, Nichol, AD, Murthy, S, Beidh, FA, Annane, D, Swaidan, LA, Beane, A, Beasley, R, Berry, LR, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Buzgau, A, Cheng, A, De Jong, M, Detry, MA, Duffy, EJ, Estcourt, LJ, Fitzgerald, M, Fowler, R, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Higgins, AM, Hills, TE, Horvat, CM, Huang, DT, King, AJ, Lamontagne, F, Lawler, PR, Lewis, R, Linstrum, K, Litton, E, Lorenzi, E, Malakouti, S, McAuley, DF, McGlothlin, A, Mcguinness, S, McVerry, BJ, Montgomery, SK, Morpeth, SC, Mouncey, PR, Orr, K, Parke, R, Parker, JC

Effect of convalescent plasma on organ support-free days in critically ill patients With COVID-19: a randomized clinical trial by Estcourt, LJ, Turgeon, AF, McQuilten, ZK, McVerry, BJ, Al-Beidh, F, Annane, D, Arabi, YM, Arnold, DM, Beane, A, Bégin, P, van Bentum-Puijk, W, Berry, LR, Bhimani, Z, Birchall, JE, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Buxton, M, Callum, JL, Chassé, M, Cheng, AC, Cove, ME, Daly, J, Derde, L, Detry, MA, De Jong, M, Evans, A, Fergusson, DA, Fish, M, Fitzgerald, M, Foley, C, Goossens, H, Gordon, AC, Gosbell, IB, Green, C, Haniffa, R, Harvala, H, Higgins, AM, Hills, TE, Hoad, VC, Horvat, C, Huang, DT, Hudson, CL, Ichihara, N, Laing, E, Lamikanra, AA, Lamontagne, F, Roberts, DJ

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method by Nasa, P, Azoulay, E, Khanna, AK, Jain, R, Gupta, S, Javeri, Y, Juneja, D, Rangappa, P, Sundararajan, K, Alhazzani, W, Antonelli, M, Arabi, YM, Bakker, J, Brochard, LJ, Deane, AM, Du, B, Einav, S, Esteban, A, Gajic, O, Galvagno, SM, Guérin, C, Jaber, S, Khilnani, GC, Koh, Y, Lascarrou, J-B, Machado, FR, Malbrain, MLNG, Mancebo, J, McCurdy, MT, McGrath, BA, Mehta, S, Mekontso-Dessap, A, Mer, M, Nurok, M, Park, PK, Pelosi, P, Peter, JV, Phua, J, Pilcher, DV, Piquilloud, L, Schellongowski, P, Schultz, MJ, Shankar-Hari, M, Singh, S, Sorbello, M, Tiruvoipati, R, Udy, AA, Welte, T, Myatra, SN

Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-cap randomized clinical trial by Higgins, AM, Berry, LR, Lorenzi, E, Murthy, S, McQuilten, Z, Mouncey, PR, Al-Beidh, F, Annane, D, Arabi, YM, Beane, A, van Bentum-Puijk, W, Bhimani, Z, Bonten, MJM, Bradbury, CA, Brunkhorst, FM, Burrell, A, Buzgau, A, Buxton, M, Charles, WN, Cove, M, Detry, MA, Estcourt, LJ, Fagbodun, EO, Fitzgerald, M, Girard, TD, Goligher, EC, Goossens, H, Haniffa, R, Hills, T, Horvat, CM, Huang, DT, Ichihara, N, Lamontagne, F, Marshall, JC, McAuley, DF, McGlothlin, A, McGuinness, SP, McVerry, BJ, Neal, MD, Nichol, AD, Parke, RL, Parker, JC, Parry-Billings, K, Peters, SEC, Reyes, LF, Rowan, KM, Saito, H, Santos, MS, Saunders, CT

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials by Axfors, C, Schmitt, AM, Janiaud, P, Van't Hooft, J, Abd-Elsalam, S, Abdo, EF, Abella, BS, Akram, J, Amaravadi, RK, Angus, DC, Arabi, YM, Azhar, S, Baden, LR, Baker, AW, Belkhir, L, Benfield, T, Berrevoets, MAH, Chen, C-P, Chen, T-C, Cheng, S-H, Cheng, C-Y, Chung, W-S, Cohen, YZ, Cowan, LN, Dalgard, O, de Almeida E Val, FF, de Lacerda, MVG, de Melo, GC, Derde, L, Dubee, V, Elfakir, A, Gordon, AC, Hernandez-Cardenas, CM, Hills, T, Hoepelman, AIM, Huang, Y-W, Igau, B, Jin, R, Jurado-Camacho, F, Khan, KS, Kremsner, PG, Kreuels, B, Kuo, C-Y, Le, T, Lin, Y-C, Lin, W-P, Lin, T-H, Lyngbakken, MN, McArthur, C, McVerry, BJ, Nichol, A